Accounts Payable

6 Months Ended

Jun. 30, 2016

Accounts Payable Disclosure [Abstract]

Accounts Payable

5. Accounts Payable

As of June 30, 2016, Current Liabilities included accounts payable of $0.1 million, comprised primarily of amounts owed for preclinical studies, corporate communications expenses, legal fees and manufacturing development and testing services. By the first week of August 2016, the June 30, 2016 amounts included in accounts payable had been substantially paid. As of December 31, 2015, Current Liabilities included accounts payable of $0.1 million.